| Literature DB >> 11353602 |
D Aubert1, L Poirel, J Chevalier, S Leotard, J M Pages, P Nordmann.
Abstract
Pseudomonas aeruginosa clinical isolate SOF-1 was resistant to cefepime and susceptible to ceftazidime. This resistance phenotype was explained by the expression of OXA-31, which shared 98% amino acid identity with a class D beta-lactamase, OXA-1. The oxa-31 gene was located on a ca. 300-kb nonconjugative plasmid and on a class 1 integron. No additional efflux mechanism for cefepime was detected in P. aeruginosa SOF-1. Resistance to cefepime and susceptibility to ceftazidime in P. aeruginosa were conferred by OXA-1 as well.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11353602 PMCID: PMC90522 DOI: 10.1128/AAC.45.6.1615-1620.2001
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191